Sakar Healthcare MD, chairman, board of directors and AGM
NSE: SAKARPharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹951.80.
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 23 Oct 2026 to consider: financial results and other business matters.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,980 Cr1,357th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 23 Oct 2026
- 46.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 23 Oct 2026
- 5.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 23 Oct 2026
- 13.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 23 Oct 2026
- 16.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026. The filing of 23 Oct 2026
- 0.13
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 7,47,09017.5% delivered
Sakar Healthcare board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorSanjay S Shah
- Managing directorAarsh S. Shah
- Company Secretary and Compliance OfficerBHARAT SONI
9 directors5 independent3 executive1 non-executive
- Sanjay S Shah · Chairperson and managing directorExecutive · joined Mar 2004 · reappointed Dec 2024 · 1 listed board · 1 committee seat
- Aarsh S. Shah · Managing directorExecutive · joined Jun 2012 · reappointed Dec 2024 · 1 listed board · 1 committee seat
- Sunil MaratheExecutive · joined Nov 2023 · 1 listed board
- Visalakshi ChandramouliNon-executive · joined Sep 2023 · 1 listed board
- Jignesh ParikhIndependent · joined Nov 2023 · 60 months as independent · 1 listed board · 1 as independent
- Khyati ShahIndependent · joined Nov 2023 · 60 months as independent · 6 listed boards · 6 as independent · 10 committee seats, 4 as chair
- Megha SamdaniIndependent · joined Jul 2025 · 60 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
- Reeya KothariIndependent · joined Jul 2025 · 60 months as independent · 4 listed boards · 4 as independent · 7 committee seats, 4 as chair
- Hiral PatelIndependent · joined Jul 2025 · 60 months as independent · 5 listed boards · 5 as independent · 5 committee seats, 1 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
4 directors who left
- Rita S. Shah, left 27 Sep 2025: Others
- Hemendrakumar Chamanlal Shah, left 27 Sep 2025: Tenure Completion
- Shailesh B. Patel, left 23 Sep 2025: Tenure Completion
- Prashant C. Srivastav, left 23 Sep 2025: Tenure Completion
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 12 May 20268 of 9 present5 independent · 95 days in between
- 5 Feb 20269 of 9 present5 independent
Audit Committee
Chair Khyati Shah
Reeya Kothari, Sanjay S Shah
- 12 May 20263 of 3 present2 independent · 95 days in between
- 5 Feb 20263 of 3 present2 independent
Nomination and remuneration committee
Chair Reeya Kothari
Hiral Patel, Megha Samdani
No meeting listed in the filing.
Stakeholders Relationship Committee
Chair Megha Samdani
Khyati Shah, Aarsh S. Shah
No meeting listed in the filing.
Corporate Social Responsibility Committee
Chair Sanjay S Shah
Aarsh S. Shah, Hiral Patel
No meeting listed in the filing.
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- J S Shah & CoPeer-review certificate valid to Jun 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Sakar Healthcare AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Sakar Healthcare share news and announcements
Annual general meeting, 22 Sep 2026
18,947 shareholders on the register on 15 Sep 2026; present: 4 promoters and 29 others; votes counted by Kashyap Mehta / KASHYAP R MEHTA AND PARTNERS.The company's voting result (opens in a new tab)
- Adoption of the Audited Standalone & Consolidated Financial Statements of the Company for the financial year ended 31st March, 2026, the Reports of the Board of Directors and Auditors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 52.44% · promoters 100.00% · institutions 0.49% · other public 2.56%
- Re-appointment of Ms. Visalakshi Chandramouli, liable to retire by rotation and being eligible, offers herself for re-appointment.Ordinary99.77% for0.23% against
Against: promoters 0.00% · institutions 100.00% · other public 0.22%
Turnout: all 52.44% · promoters 100.00% · institutions 0.49% · other public 2.56%
- Ratification of Remuneration of Cost Auditors of the Company.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 52.44% · promoters 100.00% · institutions 0.49% · other public 2.56%
- Appointment of M/s. Kashyap R Mehta & Partners, Practising Company Secretaries, a Peer Reviewed firm as Secretarial Auditors of the Company for 5 consecutive yearsOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 52.44% · promoters 100.00% · institutions 0.49% · other public 2.56%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 23 Sep 2025, 7 resolutions
7,837 shareholders on the register on 16 Sep 2025; present: 4 promoters and 44 others; votes counted by Kashyap Mehta / KASHYAP R MEHTA AND PARTNERS.The company's voting result (opens in a new tab)
- Adoption of the Audited Standalone & Consolidated Financial Statements of the Company for the financial year ended 31st March, 2025, the reports of the Board of Directors and Auditors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 53.26% · promoters 100.00% · institutions 0.00% · other public 1.81%
- Re-appointment of Mr. Sunil Marathe, liable to retire by rotation and being eligible, offers himself for re-appointmentOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 53.26% · promoters 100.00% · institutions 0.00% · other public 1.81%
- Ratification of Remuneration of Cost Auditors of the Company.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.33%
Turnout: all 53.26% · promoters 100.00% · institutions 0.00% · other public 1.81%
- Appointment of Ms. Megha Samdani as Independent Director of the Company for a period of 5 years with effect from 25th July, 2025 to 24th July, 2030Special99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 1.29%
Turnout: all 53.26% · promoters 100.00% · institutions 0.00% · other public 1.81%
- Appointment of Ms. Reeya Kothari as Independent Director of the Company for a period of 5 years with effect from 25th July, 2025 to 24th July, 2030.Special99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 1.29%
Turnout: all 53.26% · promoters 100.00% · institutions 0.00% · other public 1.81%
- Appointment of Ms. Hiral Patel as Independent Director of the Company for a period of 5 years with effect from 25th July, 2025 to 24th July, 2030.Special99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 1.29%
Turnout: all 53.26% · promoters 100.00% · institutions 0.00% · other public 1.81%
- Appointment of M/s. Nishant Pandya & Associates, Practising Company Secretaries as Secretarial Auditors of the Company for 5 consecutive years commencing from financial year 2025-26 to 2029-30Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 53.26% · promoters 100.00% · institutions 0.00% · other public 1.81%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 21 Sep 2024, 5 resolutions
Present: 4 promoters and 37 others.The company's voting result (opens in a new tab)
- ADOPTION OF DIRECTORS’ REPORT AND AUDITED STANDALONE & CONSOLIDATED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR 2023-24Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 53.57% · promoters 100.00% · institutions 0.00% · other public 1.83%
- RE-APPOINTMENT OF MR. AARSH S. SHAH AS DIRECTOR OF THE COMPANYOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 53.57% · promoters 100.00% · institutions 0.00% · other public 1.83%
- RATIFY AND CONFIRM THE REMUNERATION PAYABLE TO COST AUDITORS OF THE COMPANYOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 53.57% · promoters 100.00% · institutions 0.00% · other public 1.83%
- RE-APPOINTMENT OF MR. SANJAY S. SHAH AS MANAGING DIRECTOR OF THE COMPANY FOR A PERIOD OF 3 YEARS WITH EFFECT FROM 1ST DECEMBER, 2024 TO 30TH NOVEMBER, 2027Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 53.57% · promoters 100.00% · institutions 0.00% · other public 1.83%
- REAPPOINTMENT OF MR. AARSH S. SHAH AS JOINT MANAGING DIRECTOR OF THE COMPANY FOR A PERIOD OF THREE YEARS FROM 1ST DECEMBER, 2024 TO 30TH NOVEMBER, 2027Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 53.57% · promoters 100.00% · institutions 0.00% · other public 1.83%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Extraordinary general meeting, 20 Dec 2023, 5 resolutions
Present: 4 promoters and 29 others.The company's voting result (opens in a new tab)
- Issue of Equity Shares on Preferential Basis to the persons belonging to Non-Promoter categorySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 54.49% · promoters 100.00% · institutions 0.00% · other public 1.61%
- Issue of Warrants (Convertible Into equal number of Equity Shares) on a Preferential Basis to Person(s) and/or Entity(ies) belonging to Promoter and Non-Promoter CategoriesSpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 54.49% · promoters 100.00% · institutions 0.00% · other public 1.61%
- Appointment of Ms. Khyati Shah (DIN: 09430457) as Non Executive - Independent Director of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 54.49% · promoters 100.00% · institutions 0.00% · other public 1.61%
- Appointment of Mr. Jignesh Parikh (DIN: 01303311) as Non Executive - Independent Director of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 54.49% · promoters 100.00% · institutions 0.00% · other public 1.61%
- Appointment of Mr. Sunil Marathe (DIN: 08777180) as Whole Time Director ¿ Technical of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 54.49% · promoters 100.00% · institutions 0.00% · other public 1.61%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 7 Nov 2023, 1 resolution
Present: 0 promoters and 0 others.The company's voting result (opens in a new tab)
- Ordinary Resolution for Appointment of Ms. Vishalakshi Chandramouli (DIN: 03594109) as a Non Executive Non Independent Director of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 68.46% · promoters 100.00% · institutions 37.61% · other public 23.63%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 21 Sep 2023, 3 resolutions
Present: 4 promoters and 38 others.The company's voting result (opens in a new tab)
- Adoption of the Audited Standalone & Consolidated Financial Statements of the Company for the financial year ended 31st March, 2023, the reports of the Board of Directors and Auditors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 54.42% · promoters 100.00% · institutions 0.00% · other public 1.30%
- Re-appointment of Ms. Rita S. Shah, liable to retire by rotation and being eligible, offers herself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 54.42% · promoters 100.00% · institutions 0.00% · other public 1.30%
- Ratification of Remuneration of Cost Auditors of the Company.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 54.42% · promoters 100.00% · institutions 0.00% · other public 1.30%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Extraordinary general meeting, 29 Aug 2023, 2 resolutions
Present: 4 promoters and 34 others.The company's voting result (opens in a new tab)
- Ordinary Resolution for increase in Authorised Share capital to Rs.25 Crore and Alteration of the Capital clause in the Memorandum of Association of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 61.02% · promoters 100.00% · institutions 0.00% · other public 1.28%
- Special Resolution for issue/offer/allotment of 23,09,910 Equity Shares on Preferential basis to the Persons belonging to Non-PromoterSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 61.02% · promoters 100.00% · institutions 0.00% · other public 1.28%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Extraordinary general meeting, 20 Feb 2023, 1 resolution
Present: 4 promoters and 29 others.The company's voting result (opens in a new tab)
- Special Resolution for issue/offer/allotment of 4,22,000 Equity Shares on Preferential basis to the Persons Belongings to Non-Promoter on Preferential basisSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 62.33% · promoters 100.00% · institutions 0.00% · other public 1.09%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Sep 2025. The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Preferential IssuesJun 2025 | 8.64 | Capital expenditure for Procurement of Lipid Complex Injections Machinery and Equipments/Utilities with electrification for Oncology unit | 7.09 | 7.09 | No |